Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S., Sept. 23, 2025. Antranik Tavitian | Reuters Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive daytime sleepiness, the company said Tuesday. Centessa is…
Abivax is planning to raise money after releasing key trial data in June, its CEO told CNBC on Tuesday, signaling to potential buyers of the firm that it is in no rush to sell. Intense takeover rumors have surrounded the French biotech company for months, impacting the volatile stock that rose nearly 1,700% in 2025….
Restored Cheonggyecheon at night, Seoul. Renan Gicquel | Moment Open | Getty Images South Korea’s Kospi plunged as much as 5% Friday, leading another weak session in Asia markets after a tech-led rout on Wall Street. The South Korean index pared losses and was last down 3.20%; the small-cap Kosdaq was down 3.17%. Index heavyweights…
